Research
Alzheimer's disease
Developing digital health technologies to enable early diagnosis of dementia and tracking cognitive and functional decline in Alzheimer disease, as well as developing digital tools to improve the quality of life and functional performance of patients and minimize the burden and stress of providing care for those with dementia.
Alzheimer's disease (AD) is a progressive neurological disorder that affects the brain, leading to a decline in memory, thinking skills, and eventually the ability to carry out daily tasks. It is the most common cause of dementia, a general term for memory loss and other cognitive abilities serious enough to interfere with daily life. The disease typically begins slowly with mild memory loss and difficulty in remembering recent events. As it progresses, individuals may experience challenges in problem-solving, language, and even changes in personality.
We have a broad research program in AD that focuses on the use of digital health technologies to 1) enable early diagnosis, 2) track cognitive and functional decline over time, 3) provide validated solutions to improve quality of life and functional performance of patients with dementia and AD, and 4) minimize the burden and stress of providing care for those with dementia. Our research in AD has been supported by $10M+ of funding from the NIH.
Our clinical studies and trials in AD
BioDigit AD
Clinicaltrials.gov ID: NCT01880229
Status: Completed
Number of participants: 30
Monitoring period: 12 months
Study product: PAMSys, LEGSys, BalanSens
BioDigit AD2
Clinicaltrials.gov ID: NCT05703490
Status: Completed
Number of participants: 64
Monitoring period: 6 months
Study product: PAMSys, LEGSys, BioDigit Speech, BioDigit Video
BioDigit AD3
Clinicaltrials.gov ID: NCT05754021
Status: Ongoing
Number of participants: 100
Monitoring period: 12 months
Study product: PAMSys, LEGSys, BioDigit Speech, BioDigit Video
Care4AD clinical trial
Clinicaltrials.gov ID: NCT04308512
Status: Recruitment completed.
Number of participants: 70
Monitoring period: 6 months
Study product: PAMSys, Nili
Tele-Exergame clinical trial
Clinicaltrials.gov ID: NCT05235113
Status: Recruiting
Number of participants: 100
Monitoring period: 3 months
Study product: PAMSys, BalanSens, LEGSys, BioDigit Video
Our research partners
